{"id":8755,"date":"2009-06-05T17:45:10","date_gmt":"2009-06-05T21:45:10","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=8755"},"modified":"2009-06-05T17:45:10","modified_gmt":"2009-06-05T21:45:10","slug":"retos-nuevos-no-62-63-64-65","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/8755","title":{"rendered":"Retos Nuevos No 62-63-64-65"},"content":{"rendered":"<ul>\n<li><strong>Reto   No 62.<\/strong> Cuales agentes biol\u00f3gicos usados en psoriasis que bloquean el factor de necrosis   del tumor alfa y como efect\u00faa cada uno ese bloqueo?<strong><br \/>\n<\/strong><\/li>\n<li><strong>Reto   No 63.<\/strong> Cuales agentes biol\u00f3gicos usados en psoriasis bloquean la activaci\u00f3n de   linfocitos T?<span lang=\"ES-MX\" xml:lang=\"ES-MX\"><strong><br \/>\n<\/strong><\/span><\/li>\n<li><span lang=\"ES-MX\" xml:lang=\"ES-MX\"><strong>Reto   no 64<\/strong>. Que es el Ustekinumab y que hace en la psoriasis?<\/span><strong><br \/>\n<\/strong><\/li>\n<li><strong>Reto   No 65.<\/strong> Que cosa cl\u00ednica se considera predictiva de la temible Melanosis Neurocut\u00e1nea de   los Nevus Cong\u00e9nitos Gigantes?<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Reto No 62. Cuales agentes biol\u00f3gicos usados en psoriasis que bloquean el factor de necrosis del tumor alfa y como efect\u00faa cada uno ese bloqueo? Reto No 63. Cuales agentes biol\u00f3gicos usados en psoriasis bloquean la activaci\u00f3n de linfocitos T? Reto no 64. Que es el Ustekinumab y que hace en la psoriasis? Reto No &hellip;<\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[],"class_list":["post-8755","post","type-post","status-publish","format-standard","","category-retosasocolderma"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/8755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=8755"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/8755\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=8755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=8755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=8755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}